Search
Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
Hovione is Expanding Spray Drying Capacity for U.S. Drug Manufacturing
By David Basile, Vice President, Technical Operations
Hovione announces New Pharma Campus expansion in New Jersey
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site
Investment More Than Doubles Capacity for Spray Drying, a Critical Solubility Enhancement Technology That Could Benefit the Development of 70% of Drugs*
Cleaning Continuous Manufacturing Equipment
Pharmaceutical Technology, 2 Junho 2021
Hovione Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland
Hovione has completed significant expansions at its facilities in New Jersey, USA, and Cork, Ireland.
Spray drying
Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally